Tomohiro Ueda
Research Subjects
Tomohiro Ueda has a total of 23 co-authors. Here are the top co-authors by number of shared publications:
Atsushi Sengiku
Ueda Urology Clinic, Kyoto, Japan
1 shared publication- Emiko Okazaki
Food Processing Laboratory Tokyo University of Marine Science and Technology 108-8477 Tokyo Japan
1 shared publication Hiromitsu Negoro
Ueda Urology Clinic, Kyoto, Japan
1 shared publication- Jane M. Meijlink
International Painful Bladder Foundation, Naarden, The Netherlands
1 shared publication Jin Kono
Ueda Urology Clinic, Kyoto, Japan
1 shared publicationJunji Yonese
Department of Urology, Cancer Institute Hospital, Tokyo, Japan
1 shared publication
Latest Publications
- Open Access
- 30 December 2022
- Published by Korean Continence Society in International Neurourology Journal
- Vol. 26 (4) , 352
Reply to “Interstitial Cystitis – A Consequence of Weakened Uterosacral Ligaments Failing to Support Visceral Plexuses and Bladder Stretch Receptors and Therefore Potentially Curable?”
- 30 December 2022
- Published by Korean Continence Society in International Neurourology Journal
- Vol. 26 (4) , 352
Open AccessReply to “Interstitial Cystitis – A Consequence of Weakened Uterosacral Ligaments Failing to Support Visceral Plexuses and Bladder Stretch Receptors and Therefore Potentially Curable?”
- 5 February 2022
- Published by Wiley in International Journal of Urology
- Vol. 29 (5) , 413
Editorial Comment to Supervised machine learning algorithm identified KRT20, BATF and TP63 as biologically relevant biomarkers for bladder biopsy specimens from interstitial cystitis/bladder pain syndrome patients
- 5 February 2022
- Published by Wiley in International Journal of Urology
- Vol. 29 (5) , 413
Editorial Comment to Supervised machine learning algorithm identified KRT20, BATF and TP63 as biologically relevant biomarkers for bladder biopsy specimens from interstitial cystitis/bladder pain syndrome patients
- Open Access
- 30 June 2021
- Published by Korean Continence Society in International Neurourology Journal
- Vol. 25 (2) , 99-110
Current Understanding and Future Perspectives of Interstitial Cystitis/Bladder Pain Syndrome
Interstitial cystitis/bladder pain syndrome (IC/BPS) is a chronic disease characterized by suprapubic pain and lower urinary tract symptoms. Perhaps because of the heterogeneous nature of this disease and its multifactorial etiology, clinical trials in allinclusive populations of IC/BPS patients without phenotyping in the last decade have mainly failed to discover new therapeutic modalities of IC/BPS. Thus, phenotyping IC/BPS, aimed at identifying bladder-centric and/or bladder-beyond pathologies, including cystoscopic observation of Hunner or non-Hunner lesions of the bladder mucosa, is particularly important for the future of IC/BPS management. Based on recent discussions at international conferences, including the International Consultation on IC, Japan, it has been proposed that Hunner-lesion IC should be separated from other non-Hunner IC/BPS because of its distinct inflammatory profiles and epithelial denudation compared with non-Hunner IC/BPS. However, there are still no standard criteria for the diagnosis of Hunner lesions other than typical lesions, while conventional cystoscopic observations may miss atypical or small Hunner lesions. Furthermore, diagnosis of the bladder-centric phenotype of IC/BPS requires confirmation that identified mucosal lesions are truly a cause of bladder pain in IC/BPS patients. This review article discusses the current status of IC/BPS pathophysiology and diagnosis, as well as future directions of the proper diagnosis of bladder-centric IC/BPS, in which pathophysiological mechanisms other than those in inflammatory pathways, such as angiogenic and immunogenic abnormalities, could also be involved in both Hunner-lesion IC and non-Hunner IC/BPS. It is hoped that this new paradigm in the pathophysiological evaluation and diagnosis of IC/BPS could lead to pathology-based phenotyping and new treatments for this heterogeneous disease.
- 30 June 2021
- Published by Korean Continence Society in International Neurourology Journal
- Vol. 25 (2) , 99-110
Open AccessCurrent Understanding and Future Perspectives of Interstitial Cystitis/Bladder Pain Syndrome
Interstitial cystitis/bladder pain syndrome (IC/BPS) is a chronic disease characterized by suprapubic pain and lower urinary tract symptoms. Perhaps because of the heterogeneous nature of this disease and its multifactorial etiology, clinical trials in allinclusive populations of IC/BPS patients without phenotyping in the last decade have mainly failed to discover new therapeutic modalities of IC/BPS. Thus, phenotyping IC/BPS, aimed at identifying bladder-centric and/or bladder-beyond pathologies, including cystoscopic observation of Hunner or non-Hunner lesions of the bladder mucosa, is particularly important for the future of IC/BPS management. Based on recent discussions at international conferences, including the International Consultation on IC, Japan, it has been proposed that Hunner-lesion IC should be separated from other non-Hunner IC/BPS because of its distinct inflammatory profiles and epithelial denudation compared with non-Hunner IC/BPS. However, there are still no standard criteria for the diagnosis of Hunner lesions other than typical lesions, while conventional cystoscopic observations may miss atypical or small Hunner lesions. Furthermore, diagnosis of the bladder-centric phenotype of IC/BPS requires confirmation that identified mucosal lesions are truly a cause of bladder pain in IC/BPS patients. This review article discusses the current status of IC/BPS pathophysiology and diagnosis, as well as future directions of the proper diagnosis of bladder-centric IC/BPS, in which pathophysiological mechanisms other than those in inflammatory pathways, such as angiogenic and immunogenic abnormalities, could also be involved in both Hunner-lesion IC and non-Hunner IC/BPS. It is hoped that this new paradigm in the pathophysiological evaluation and diagnosis of IC/BPS could lead to pathology-based phenotyping and new treatments for this heterogeneous disease.
- 24 June 2021
- Published by Wiley in International Journal of Urology
- Vol. 28 (8) , 831-832
Editorial Comment from Dr Ueda to Decreased urothelial cytoskeleton and cell proliferation protein expression suggest interstitial cystitis/bladder pain syndrome patients with Hunner’s lesion and grade 3 glomerulation might be different from other types of patients
- 24 June 2021
- Published by Wiley in International Journal of Urology
- Vol. 28 (8) , 831-832
Editorial Comment from Dr Ueda to Decreased urothelial cytoskeleton and cell proliferation protein expression suggest interstitial cystitis/bladder pain syndrome patients with Hunner’s lesion and grade 3 glomerulation might be different from other types of patients
- Open Access
- 30 May 2019
- Published by Wiley in International Journal of Urology
- Vol. 26 (S1) , 53-56
Low bladder capacity is an important predictor for comorbidity of interstitial cystitis with Hunner's lesion in patients with refractory chronic prostatitis/chronic pelvic pain syndrome
Objective: To evaluate the predictive factors for comorbidity of Hunner‐type interstitial cystitis in patients with chronic prostatitis/chronic pelvic pain syndrome using urethrocystoscopy.Methods: Thirty‐two male patients were included in this study. Between April 2012 and April 2016; they were diagnosed with chronic prostatitis/chronic pelvic pain syndrome according to the National Institutes of Health classification. Their symptoms were not improved by 3 months of behavioral and pharmacological therapies. They all underwent narrow band imaging‐assisted urethrocystoscopy to assess whether the presence of Hunner's lesions correlated with other variables.Results: Thirteen out of 32 patients (41%) had Hunner's lesions. Of the variables, maximal voided volume per micturition (106 ± 29 mL vs 171 ± 61 mL) and bladder capacity (267 ± 121 mL vs 407 ± 137 mL) were significantly smaller in patients with Hunner's lesions compared to those without. Other variables, apart from age, were not significantly different. Furthermore, patients with voided volume less than 150 mL were more likely to have Hunner's lesions than those with voided volume exceeding 150 mL.Conclusions: Hunner‐type interstitial cystitis is a common comorbidity among patients with refractory chronic prostatitis/chronic pelvic pain syndrome. In cases where voided volume is small, performing narrow band imaging‐assisted urethrocystoscopy would be very helpful for detecting bladder mucosal changes such as Hunner's lesions.
- 30 May 2019
- Published by Wiley in International Journal of Urology
- Vol. 26 (S1) , 53-56
Open AccessLow bladder capacity is an important predictor for comorbidity of interstitial cystitis with Hunner's lesion in patients with refractory chronic prostatitis/chronic pelvic pain syndrome
Objective: To evaluate the predictive factors for comorbidity of Hunner‐type interstitial cystitis in patients with chronic prostatitis/chronic pelvic pain syndrome using urethrocystoscopy.Methods: Thirty‐two male patients were included in this study. Between April 2012 and April 2016; they were diagnosed with chronic prostatitis/chronic pelvic pain syndrome according to the National Institutes of Health classification. Their symptoms were not improved by 3 months of behavioral and pharmacological therapies. They all underwent narrow band imaging‐assisted urethrocystoscopy to assess whether the presence of Hunner's lesions correlated with other variables.Results: Thirteen out of 32 patients (41%) had Hunner's lesions. Of the variables, maximal voided volume per micturition (106 ± 29 mL vs 171 ± 61 mL) and bladder capacity (267 ± 121 mL vs 407 ± 137 mL) were significantly smaller in patients with Hunner's lesions compared to those without. Other variables, apart from age, were not significantly different. Furthermore, patients with voided volume less than 150 mL were more likely to have Hunner's lesions than those with voided volume exceeding 150 mL.Conclusions: Hunner‐type interstitial cystitis is a common comorbidity among patients with refractory chronic prostatitis/chronic pelvic pain syndrome. In cases where voided volume is small, performing narrow band imaging‐assisted urethrocystoscopy would be very helpful for detecting bladder mucosal changes such as Hunner's lesions.
- 1 April 2014
- Published by Wiley in International Journal of Urology
- Vol. 21 (S1) , 84
Editorial Comment from Dr Ueda to Assessments of bladder pain syndrome/interstitial cystitis treatment in future trials
- 1 April 2014
- Published by Wiley in International Journal of Urology
- Vol. 21 (S1) , 84
Editorial Comment from Dr Ueda to Assessments of bladder pain syndrome/interstitial cystitis treatment in future trials
- Open Access
- 1 January 1997
- Published by Japanese Society of Fisheries Science in NIPPON SUISAN GAKKAISHI
- Vol. 63 (4) , 600-607
Effect of Heating on Quality of Pressure-Texturized Gels from Chum Salmon Mince.
- 1 January 1997
- Published by Japanese Society of Fisheries Science in NIPPON SUISAN GAKKAISHI
- Vol. 63 (4) , 600-607
Open AccessEffect of Heating on Quality of Pressure-Texturized Gels from Chum Salmon Mince.
- Open Access
- 1 June 1994
- Published by Wiley in International Journal of Urology
- Vol. 1 (2) , 185-186
SYNCHRONOUS INVERTED PAPILLOMA AND SUBMUCOSAL LEIOMYOMA OF THE URINARY BLADDER
We report a case of synchronous inverted papilloma and submucosal leiomyoma of the bladder in
- 1 June 1994
- Published by Wiley in International Journal of Urology
- Vol. 1 (2) , 185-186
Open AccessSYNCHRONOUS INVERTED PAPILLOMA AND SUBMUCOSAL LEIOMYOMA OF THE URINARY BLADDER
We report a case of synchronous inverted papilloma and submucosal leiomyoma of the bladder in